Several cell-intrinsic effectors drive type I interferon-mediated restriction of HIV-1 in primary CD4+ T cells
Abstract
Type I interferon (IFN) upregulates proteins that inhibit HIV within infected cells. Prior studies have identified IFN-stimulated genes (ISGs) that impede lab-adapted HIV in cell lines, yet the ISG(s) that mediate IFN restriction in HIV target cells, primary CD4+ T cells, are unknown. Here, we interrogate ISG restriction of primary HIV in CD4+ T cells. We performed CRISPR-knockout screens using a custom library that specifically targets ISGs expressed in CD4+ T cells and validated top hits. Our investigation identified new HIV-restricting ISGs (HM13, IGFBP2, LAP3) and found that two previously studied factors (IFI16, UBE2L6) are IFN effectors in T cells. Inactivation of these five ISGs in combination further diminished IFNs protective effect against six diverse HIV strains. This work demonstrates that IFN restriction of HIV is multifaceted, resulting from several effectors functioning collectively, and establishes a primary cell ISG screening model to identify both single and combinations of HIV-restricting ISGs.
02 /Specification & Classification
Click any tag to browse matching papers- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- A Virus-Packageable CRISPR Screen Identifies Host Factors Mediating Interferon Inhibition of HIV
M. Ohainle, L. Pendergast, … M. Emerman·bioRxiv·Jul 20, 2018
- Differential Control of HIV-1 Replication by IFN-α14 Compared to IFN-α2 Relates to Differences in the Modulation of Host Antiretroviral Restriction Factors
Saurav Saswat Rout, Madeline T.E. Stewart, … Kerry J. Lavender·bioRxiv·Nov 1, 2025
- Interferon-α subtype treatment induces the repression of SRSF1 in HIV-1 target cells and affects HIV-1 post integration steps
H. Sertznig, F. Roesmann, … M. Widera·bioRxiv·Jun 11, 2021
- HIV-1 derived replication intermediates/oligonucleotides induce a type I IFN-dependent immune suppression via STING activation that can be restored by targeting IFNARI
Cecilia Svanberg, Ravi Prasad Mukku, … Marie Larsson·bioRxiv·Feb 17, 2025
- Tumor necrosis factor receptor 2 inhibits HIV-1 infection by blocking the binding of gp120 to CD4
Yang Gao, Zhonghao Chen, … Xin Chen·International Journal of Biological SciencesPeer-reviewed·Apr 8, 2026
- HIV-1 Vpr Degrades TET2 to Suppress IRF7 and Interferon Expression in Plasmacytoid Dendritic Cells